Comparison of receptors and enzymes regulating cholesterol levels in liver between SHR/NDmcr-cp rats and normotensive Wistar Kyoto rats at ten weeks of age

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 7, 2011, Pages 1116-1119

  Michihara, Akihiro ^a   Anraku, Makoto ^a   Abe, Aoi ^a   Kinoshita, Haruko ^a   Kamizaki, Yohei ^a   Tomida, Hisao ^a   Akasaki, Kenji ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Cholesterol; Metabolic syndrome; Mevalonate pyrophosphate decarboxylase; SHR NDmcr cp; Wistar Kyoto rat

Indexed keywords

CARBOXYLYASE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME; DIPHOSPHOMEVALONATE DECARBOXYLASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PROTEIN CYP8B1; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYP7A1 GENE; CYP8B1 GENE; ENZYME REGULATION; GENE; LIPID LIVER LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LIVER FUNCTION; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MALE; METABOLIC REGULATION; MEVALONATE PYROPHOSPHATE DECARBOXYLASE GENE; NONHUMAN; RAT; RECEPTOR GENE; SCAVENGER RECEPTOR BI GENE; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; WISTAR KYOTO RAT;

ANIMALS; BASE SEQUENCE; CHOLESTEROL; DNA PRIMERS; ENZYMES; LIVER; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79960294213     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1116     Document Type: Article

References (11)

1. Takaya K., Ogawa Y., Hiraoka J., Hosoda K., Yamori Y., Nakao K., Koletsky R. J., Nat. Genet., 14, 130-131 (1996).
2. Bhathena S. J., Kennedy B. W., Jones J., Smith P. M., Michaelis O. E. 4th, Carswell N., Hansen C. T., Voyles N. R., Recant L., Proc. Soc. Exp. Biol. Med., 192, 66-71 (1989).
3. Michaelis O. E. 4th, Ellwood K. C., Judge J. M., Schoene N. W., Hansen C. T., Am. J. Clin. Nutr., 39, 612-618 (1984).
4. Kagota S., Tanaka N., Kubota Y., Yamaguchi Y., Nakamura K., Kunitomo M., Shinozuka K., Clin. Exp. Pharmacol. Physiol., 31 (Suppl. 2), S54-S56 (2004).
5. Nangaku M., Izuhara Y., Usuda N., Inagi R., Shibata T., Sugiyama S., Kurokawa K., van Ypersele de Strihou C., Miyata T., Nephrol. Dial. Transplant., 20, 2661-2669 (2005).
6. Kagota S., Tada Y., Nejime N., Nakamura K., Kunitomo M., Shinozuka K., J. Pharmacol. Sci., 109, 556-564 (2009).
7. Anraku M., Michihara A., Yasufuku T., Akasaki K., Tsuchiya D., Nishio H., Maruyama T., Otagiri M., Maezaki Y., Kondo Y., Tomida H., Biol. Pharm. Bull., 34, 1994-1998 (2010).
8. Connelly M. A., Williams D. L., Endocr. Res., 30, 697-703 (2004).
9. Tsutsumi K., Hagi A., Inoue Y., Biol. Pharm. Bull., 24, 579-581 (2001).
10. Kudo M., Noshiro M., Aoyama Y., Yoshida Y., Clin. Exp. Pharmacol. Physiol., 31 (Suppl. 2), S57-S59 (2004).
11. Chen G. P., Yao L., Lu X., Li L., Hu S. J., Acta Pharmacol. Sin., 29, 1181-1186 (2008).